Free Trial

NovoCure (NVCR) SEC Filings & 10K Form

NovoCure logo
$12.33 +0.31 (+2.58%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$12.32 -0.01 (-0.04%)
As of 08/29/2025 07:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent NovoCure SEC Filings

DateFilerForm TypeView
08/28/2025
6:03 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2025
11:56 AM
Capital World Investors (Filed by)
NovoCure (Subject)
Form SCHEDULE 13G
07/30/2025
3:33 PM
Brackmann Christoph (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2025
6:01 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2025
6:02 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2025
12:42 PM
Capital International Investors (Filed by)
NovoCure (Subject)
Form SCHEDULE 13G/A
06/06/2025
3:26 PM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2025
3:13 PM
NovoCure (Issuer)
VERNON W ANTHONY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
3:14 PM
Hung David (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
3:15 PM
NovoCure (Issuer)
Scannell Timothy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
3:16 PM
NovoCure (Issuer)
Ocean Allyson J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
3:17 PM
HILLEMAN JERYL L (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
3:19 PM
Madden Martin J. (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:26 PM
NovoCure (Issuer)
Stafford Kristin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
3:25 PM
Leonard Frank X (Reporting)
NovoCure (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/02/2025
5:05 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2025
3:17 PM
NovoCure (Issuer)
Paravasthu Mukund (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2025
6:01 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2025
6:02 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
7:00 PM
BlackRock, Inc. (Filed by)
NovoCure (Subject)
Form SCHEDULE 13G/A
04/22/2025
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2025
6:01 AM
NovoCure (Filer)
Form DEF 14A
04/21/2025
6:02 AM
NovoCure (Filer)
Form DEFA14A
04/01/2025
4:00 PM
NovoCure (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
Form SCHEDULE 13G
03/06/2025
3:40 PM
NovoCure (Issuer)
Paravasthu Mukund (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:41 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:41 PM
NovoCure (Issuer)
Weinberg Uri (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:41 PM
NovoCure (Issuer)
Puri Michal Nath (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:42 PM
Ben Arye Barak (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:42 PM
Leupin Nicolas (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:48 PM
Brackmann Christoph (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
8:27 PM
NovoCure (Issuer)
Weinberg Uri (Reporting)
Form 4/A
03/03/2025
8:26 PM
NovoCure (Issuer)
Paravasthu Mukund (Reporting)
Form 4/A
03/03/2025
8:26 PM
Leupin Nicolas (Reporting)
NovoCure (Issuer)
Form 4/A
03/03/2025
8:26 PM
NovoCure (Issuer)
Puri Michal Nath (Reporting)
Form 4/A
03/03/2025
8:26 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 4/A
03/03/2025
8:26 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4/A
03/03/2025
4:31 PM
NovoCure (Subject)
Paravasthu Mukund (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
4:34 PM
Leonard Frank X (Reporting)
NovoCure (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
4:01 PM
NovoCure (Subject)
Weinberg Uri (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
3:43 PM
Cordova Ashley (Reporting)
NovoCure (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Altucher: It Looks Like My Trump prediction is coming true (Ad)

New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun. Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation.tc pixel

See Altucher’s Trump crypto prediction here
02/28/2025
3:50 PM
NovoCure (Subject)
Paravasthu Mukund (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
3:36 PM
GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
6:01 AM
NovoCure (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
6:02 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
6:05 AM
NovoCure (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/15/2025
3:23 PM
NovoCure (Issuer)
Paravasthu Mukund (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:28 PM
NovoCure (Subject)
Paravasthu Mukund (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:27 PM
NovoCure (Issuer)
Paravasthu Mukund (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
6:02 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
6:00 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/15/2024
3:05 PM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
5:21 PM
NovoCure (Issuer)
Paravasthu Mukund (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2024
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NVCR) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners